DGLYX
Price
$17.40
Change
-$0.23 (-1.30%)
Updated
Sep 8 closing price
Net Assets
363.44M
RNPAX
Price
$68.88
Change
-$0.01 (-0.01%)
Updated
Sep 8 closing price
Net Assets
165.87B
Interact to see
Advertisement

DGLYX vs RNPAX

DGLYX vs RNPAX Comparison Chart in %
View a ticker or compare two or three
VS
DGLYX vs. RNPAX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLYX is a Hold and RNPAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPAX has more cash in the bank: 166B vs. DGLYX (363M). RNPAX pays higher dividends than DGLYX: RNPAX (0.36) vs DGLYX (0.33). DGLYX was incepted earlier than RNPAX: DGLYX (13 years) vs RNPAX (24 years). RNPAX (1.49) is less costly to investors than DGLYX (0.90). RNPAX is a more actively managed with annual turnover of: 23.00 vs. DGLYX (10.03). RNPAX has a lower initial minimum investment than DGLYX: RNPAX (250) vs DGLYX (1000000). RNPAX annual gain was more profitable for investors over the last year : 4.81 vs. DGLYX (-18.55). RNPAX return over 5 years is better than : 5.94 vs. DGLYX (-40.75).
DGLYXRNPAXDGLYX / RNPAX
Total Expense Ratio0.901.4960%
Annual Report Gross Expense Ratio0.901.4960%
Fund Existence13 years24 years-
Gain YTD2.7996.92340%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets363M166B0%
Annual Yield % from dividends0.330.3690%
Returns for 1 year-18.554.81-386%
Returns for 3 years-23.0236.83-62%
Returns for 5 years-40.755.94-686%
Returns for 10 years0.4297.750%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PALI2.200.11
+5.26%
Palisade Bio
RNGTU11.36N/A
N/A
Range Capital Acquisition Corp II
PRLB81.03-0.41
-0.50%
Proto Labs
R246.89-1.55
-0.62%
Ryder System
IZEA2.94-0.05
-1.67%
IZEA Worldwide